Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Lissencephaly (LIS) due to TUBA1A mutation is a congenital cortical development anomaly due to abnormal neuronal migration involving neocortical and hippocampal lamination, corpus callosum, cerebellum and brainstem. A large clinical spectrum can be observed, from children with severe epilepsy and intellectual and motor deficit to cases with severe cerebral dysgenesis in the antenatal period leading to pregnancy termination due to the severity of the prognosis.
Features include very common findings: Enlarged brain ventricles (ventriculomegaly), Global developmental delay, and Dysgenesis of the basal ganglia; and common findings: Bilateral tonic-clonic seizure, Hypoplasia of the brainstem, Seizure, and Agenesis of corpus callosum and others. 38 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 11 | Bilateral tonic-clonic seizure, Hypoplasia of the brainstem, Seizure |
TUBA1A function has not been fully characterized.
Lissencephaly due to TUBA1A mutation is associated with mutations in the TUBA1A gene on chromosome 12.
Genetic testing for TUBA1A is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for lissencephaly due to TUBA1A mutation has been reported in the published literature.
Phenotype severity distribution: 3 very common features, 16 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for lissencephaly due to TUBA1A mutation.
5 publications have been identified in PubMed for lissencephaly due to TUBA1A mutation. Research spans Case Report / Case Series (60%), Diagnostic / Biomarker (20%), and Epidemiology / Natural History (20%).
Proepper CR (2026). [PMID: 42177523](https://pubmed.ncbi.nlm.nih.gov/42177523/). *Orphanet J Rare Dis*. [Epidemiology / Natural History]
Furukawa S (2024). [PMID: 39123069](https://pubmed.ncbi.nlm.nih.gov/39123069/). *J Hum Genet*. [Diagnostic / Biomarker]
Srivastava P (2024). [PMID: 38912084](https://pubmed.ncbi.nlm.nih.gov/38912084/). *Cureus*. [Case Report / Case Series]
Ren S (2024). [PMID: 38813542](https://pubmed.ncbi.nlm.nih.gov/38813542/). *Front Pediatr*. [Case Report / Case Series]
Saidin A (2024). [PMID: 39202391](https://pubmed.ncbi.nlm.nih.gov/39202391/). *Genes (Basel)*. [Case Report / Case Series]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 12:55 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Eyes | 3 | Strabismus, Optic nerve hypoplasia, Nystagmus |
Muscles | 2 | Low muscle tone (hypotonia), Generalized hypotonia |
Head and neck | 1 | Microcephaly |
Arms and legs | 1 | Hypoplastic anterior limbs of the internal capsule |